Esperion Therapeutics Inc (LTS:0IIM)
$ 2.135 0.1668 (8.47%) Market Cap: 424.83 Mil Enterprise Value: 504.66 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 50/100

Esperion Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 10:20PM GMT
Release Date Price: $5.57
Unidentified Analyst

And we're thrilled to have with us today Esperion. And speaking on behalf of Esperion with the new presentation is CEO, Sheldon Koenig. Sheldon?

Sheldon L. Koenig
Esperion Therapeutics, Inc. - President, CEO & Director

Great. Thanks, [Jeff]. Appreciate it. Good afternoon, everybody, and thank you on behalf of Esperion Therapeutics. Really appreciate your time here to listen to our story. We have an exciting story, and let's get right to it. So just our forward-looking statement. We have to look back because I can't really see the screen. So if you don't mind, I'll pay my attention to the screen and pay my attention to you as well. And hopefully, we'll have a little bit of time for Q&A afterwards.

So just to focus on Esperion, we've been evolving into really a unique cardiometabolic business. This company started in 2008 by Dr. Roger Newton. And some of you might be familiar with Dr. Newton. He was actually the Founder -- Co-Founder of Lipitor. And this was a company that was in Pfizer, then spun out of Pfizer. And as you know,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot